{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:12:41Z","timestamp":1785683561049,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.anndiagpath.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T08:00:48Z","timestamp":1493280048000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["CD30 + T cell enriched primary cutaneous CD4 + small\/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4 + T cell lymphoproliferative disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Cynthia M.","family":"Magro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton G.","family":"Fulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2017.04.009_bb0005","series-title":"World Health Organization classification of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.anndiagpath.2017.04.009_bb0010","first-page":"593","article-title":"HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients","volume":"121","author":"Sterry","year":"1989","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2017.04.009_bb0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archderm.1995.01690210039007","article-title":"Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French study group on cutaneous lymphomas","volume":"131","author":"Friedmann","year":"1995","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2017.04.009_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DAD.0b013e318297f7fd","article-title":"Indolent CD8+ lymphoid proliferation of the face with eyelid involvement","volume":"36","author":"Hagen","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2017.04.009_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0560.2009.01278.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?","volume":"37","author":"Beltraminelli","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2017.04.009_bb0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2017.04.009_bb0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4+ primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.anndiagpath.2017.04.009_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pde.12168","article-title":"Primary cutaneous CD4+ small to medium-size pleomorphic T-cell lymphoma in a 12-year-old girl","volume":"30","author":"Volks","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2017.04.009_bb0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/cup.12204","article-title":"Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype","volume":"40","author":"Buder","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2017.04.009_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1346-8138.12493","article-title":"Case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified, with characteristics of follicular helper T cells","volume":"41","author":"Takaki","year":"2014","journal-title":"J Dermatol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2017.04.009_bb0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archdermatol.2011.3269","article-title":"Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphomareported in a series of 5 cases","volume":"148","author":"Battistella","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2017.04.009_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/DAD.0000000000000597","article-title":"Differential NFATc1 expression in primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma and other forms of cutaneous T-cell lymphoma and pseudolymphoma","volume":"39","author":"Magro","year":"2017","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2017.04.009_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/icb.2013.62","article-title":"Priming of T follicular helper (Tfh) cells by dendritic cells","volume":"92","author":"Ballesteros-Tato","year":"2014","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2017.04.009_bb0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaci.2015.04.001","article-title":"Skin DC induce follicular helper T cells and protective humoral immune responses","volume":"136","author":"Yao","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anndiagpath.2017.04.009_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1309\/AQMU3JFE2A66LC7E","article-title":"Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles","volume":"128","author":"Magro","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2017.04.009_bb0080","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cup.12169","article-title":"Primary cutaneous CD4 positive small\/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells","volume":"40","author":"Zhang","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"20","key":"10.1016\/j.anndiagpath.2017.04.009_bb0085","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2017.04.009_bb0090","first-page":"1169","article-title":"Prognostic significance of CD30 (Ki-1\/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients","volume":"135","author":"Beljaards","year":"1989","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2017.04.009_bb0095","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2017.04.009_bb0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0888-7543(05)80203-4","article-title":"Assignment of the human CD30 (Ki-1) gene to 1p36","volume":"14","author":"Fonatsch","year":"1992","journal-title":"Genomics"},{"issue":"Suppl. 4","key":"10.1016\/j.anndiagpath.2017.04.009_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/annonc\/7.suppl_4.S19","article-title":"Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease","volume":"7","author":"Gruss","year":"1996","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2017.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.anndiagpath.2017.04.009_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.1994.tb00549.x","article-title":"Classification of primary cutaneous T-cell lymphomas","volume":"24","author":"Willemze","year":"1994","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.anndiagpath.2017.04.009_bb0120","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","article-title":"Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity","volume":"86","author":"Shiota","year":"1995","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.anndiagpath.2017.04.009_bb0125","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.anndiagpath.2017.04.009_bb0130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0002-9440(10)65018-3","article-title":"Regulation of CD30 antigen expression and its potential significance for human disease","volume":"156","author":"Kadin","year":"2000","journal-title":"Am J Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T20:20:29Z","timestamp":1719174029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913417301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":26,"alternative-id":["S1092913417301144"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.04.009","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD30+ T cell enriched primary cutaneous CD4+ small\/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}